leisure time -WSS

leisure time

author：explore 2025-09-14 21:59:38 - browse：21845

Adobe

LONDON — Merck said Wednesday it is buying ophthalmology-focused startup EyeBio in a deal worth up to $3 billion, as the pharma company looks to diversify its pipeline.

Under the deal, Merck, through a subsidiary, will pay $1.3 billion in cash upfront, with another $1.7 billion potentially included if certain regulatory and commercial milestones are met. The Wall Street Journal first reported the news Tuesday night.

EyeBio has been developing a drug called restoret for a number of retinal diseases, including age-related macular degeneration and diabetic macular edema. It presented data in February from a Phase 1/2 trial of restoret in both conditions. Merck said it plans to move restoret into a pivotal trial for diabetic macular edema later this year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： New Alzheimer's drugs heat up race for early detection blood tests

Wikipedia

WSS

How doctors’ personal politics affect patients

The battle over 'scope creep' and who gets to be called 'doctor'

Sweden knocks USA out of World Cup in penalty kicks

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

How CRISPR works, explained in two minutes

Restaurant meals are packed with calories, and we still keep eating them

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Wikipedia

Cancer drug shortages should be causing more outrage

Device maker Teleflex to acquire urology company for $600M

Wildfire smoke exposes gaps in outdoor worker protections

STAT Report: Patient voices and perspectives

Psychedelics group wrestles with new pharma identity

Former reverend arrested for allegedly killing 8

Anesthesiologist group: stop taking Ozempic before surgery

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

George Santos makes 1st court appearance after pleading not guilty to 13 counts

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

hotspot

Biogen says it will cut costs by $700 million, slash 1,000 jobs

A new crop of companies is reshaping the health data economy

It was time to plan for my old age. If only I could stop crying

Search called off for baby washed away in Pennsylvania flash flood

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

Restaurant meals are packed with calories, and we still keep eating them

Wikipedia

focus

Wikipedia

focus